Ordaos Bio

About:

Ordaos creates bespoke mini-proteins to help drug hunters deliver life-saving treatments.

Website: https://ordaos.bio

Top Investors: Future Labs, IAG Capital Partners, Citta Capital, Route 66 Ventures, SeedFolio

Description:

Ordaōs is a human-enabled, machine-driven drug design company. We create customized mini-proteins that help pharma and biotechs around the world deliver safer and more effective life-saving treatments in a fraction of the time of traditional discovery methods. miniPRO proteins are created and evaluated in silico, and then rigorously tested in vitro, which enables us to reliably and repeatedly deliver de novo solutions that meet our client’s stringent requirements at scale, including novelty and probability of clinical success. At Ordaōs, we help birth novel therapies that reduce patient suffering, improve health, and extend life.